Invasive Fungal Infections: all 136 studies
Page 1 of 2. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.
- mNGS for IFD in Patients With Hematological MalignanciesNot yet recruitingNCT07763184
- Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia PatientsRecruitingNCT07763054
- Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic ChildrenRecruitingNCT07725263
- A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis Treated With Olorofim Plus Baseline Standard of Care or Placebo Plus Baseline Standard of CareNot yet recruitingNCT07712484Phase 2
- Liposomal Amphotericin B for Invasive Fungal Disease in Solid Organ Transplant RecipientsNot yet recruitingNCT07656493
- Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNCT07569055
- Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological PatientsNot yet recruitingNCT07559032Not applicable
- Study on the Pharmacokinetic Characteristics of Liposomal Amphotericin B in Patients With Invasive Fungal Infections Undergoing Plasma Exchange TherapyNot yet recruitingNCT07532850
- A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins ProphylaxisRecruitingNCT07357038
- Emerging Indications for Hyperbaric Oxygen TreatmentNot yet recruitingNCT07240649Phase 4
- Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD（ Breakthrough Invasive Fungal Disease） in Patients With Malignant Hematological DiseasesRecruitingNCT07135778
- Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal DiseaseRecruitingNCT06819410
- Population Pharmacokinetics of L-AmB in Chinese Patients Assisted by Extracorporeal Membrane Pulmonary Oxygenation (ECMO)Not yet recruitingNCT06754436Phase 4
- Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHDEnrolling by invitationNCT06698211
- Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal InfectionRecruitingNCT06678113Phase 1/2
- L-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxisEnrolling by invitationNCT06640296
- Breath Analysis for the Detection of Invasive Fungal InfectionsRecruitingNCT06537726
- Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant PatientsRecruitingNCT06498310
- Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal InfectionsAvailableNCT06433128
- Observational Study on Invasive Fungal Infection Incidence in Ph-neg Acute Lymphoblastic Leukemia PatientsRecruitingNCT06392581
- A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal DiseaseNot yet recruitingNCT06376201Phase 4
- Immunomonitoring of Mold Invasive InfectionsRecruitingNCT06285188
- PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.Not yet recruitingNCT06220370
- Factors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly PatientsRecruitingNCT06137690
- Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtionsRecruitingNCT06105411
- Fungal Surveillance in BangladeshRecruitingNCT06103331
- Usefulness of PET-CT for Invasive Fungal InfectionRecruitingNCT05688592
- Biomarkers for Invasive MucormycosisRecruitingNCT05406037
- To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver TransplantationNot yet recruitingNCT04728971Phase 4
- Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)RecruitingNCT04665037Phase 2
- Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell TransplantsRecruitingNCT03717623Phase 4
- FungiScope - A Global Emerging Fungal Infection RegistryRecruitingNCT01731353
- Natural History of Individuals With Immune System Problems That Lead to Fungal InfectionsRecruitingNCT01386437
- Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous FungiCompletedNCT05630976Phase 4Results posted
- Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare MoldsTerminatedNCT04240886Phase 2Results posted
- Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive CandidiasisCompletedNCT03667690Phase 3Results posted
- Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment OptionsCompletedNCT03583164Phase 2Results posted
- Endemic Mycoses Treatment With SUBA-itraconazole vs ItraconazoleCompletedNCT03572049Phase 2/3Results posted
- Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute LeukaemiaCompletedNCT01615809Phase 2Results posted
- A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell TransplantationCompletedNCT01519648Results posted
- Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid LeukemiaCompletedNCT01307579Phase 3Results posted
- Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic LeukemiaCompletedNCT01259713Phase 3Results posted
- Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal InfectionCompletedNCT01137292Results posted
- Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In KoreaCompletedNCT01073631Results posted
- Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IVCompletedNCT01073618Results posted
- Beta Glucan Assay in Patients Receiving Voriconazole ProphylaxisCompletedNCT00904995Phase 3Results posted
- Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)CompletedNCT00750737Phase 3Results posted
- Anidulafungin PK in Infants and ToddlersCompletedNCT00734500Phase 1Results posted
- Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare FungiCompletedNCT00634049Phase 3Results posted
- Isavuconazole (BAL8557) for Primary Treatment of Invasive AspergillosisCompletedNCT00412893Phase 3Results posted
- Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)CompletedNCT00289991Phase 3Results posted
- Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell TransplantsCompletedNCT00143312Phase 4Results posted
- Isavuconazole Therapeutic Drug Monitoring in Transplant RecipientsCompletedNCT07716878
- Hyperbaric Oxygen Therapy Used on Severely Injured Healthy Individuals With Fungal InfectionsActive, not recruitingNCT07120581
- Human Bioequivalence Study of Liposomal Amphotericin B for InjectionCompletedNCT06983665Not applicable
- Human Bioequivalence Study of Amphotericin B Liposome for InjectionCompletedNCT06977490Not applicable
- Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant RecipientsCompletedNCT06654076
- Micafungin Versus Amphotercine B in Treatment of Invasive Fungal InfectionCompletedNCT06413056Phase 4
- Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province (IFS)Status unknownNCT06346951
- Mucorales PCR Screening in At-risk Hematology PatientsCompletedNCT05925660Not applicable
- Population Pharmacokinetics and Dose Optimization of Caspofungin in AdolescentsCompletedNCT05881109
- Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negativeCompletedNCT05750706
- Pharmacokinetics and Safety of AmBisome and DKF-5122CompletedNCT05749380Phase 1
- Using of Biomarkers and Blood Culture in Early Detection of Systemic InfectionsStatus unknownNCT05737537Not applicable
- Evaluation of a Clinical Decision Support System for Fungal InfectionsCompletedNCT05656157
- Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased PatientsCompletedNCT05611892
- LFD of Aspergillus Antigen in PaediatricsStatus unknownNCT05569824
- Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of AgeTerminatedNCT05534529Phase 1
- A Bioequivalence Study of APX001 High-load and Low-load TabletsCompletedNCT05491733Phase 1
- Pharmacokinetics of Fluconazole in Children (2-18 Years)Status unknownNCT05130723
- To Evaluate the Efficacy and Safety of ABCD in the Treatment of IFDStatus unknownNCT05116059
- Olorofim Aspergillus Infection StudyCompletedNCT05101187Phase 3
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.Status unknownNCT04921254Phase 1
- Fugal Infection in COVID-19 PatientsStatus unknownNCT04914013
- Pharmacokinetics of Isavuconazole in Patients in the Intensive Care UnitCompletedNCT04777058
- Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological TumorsStatus unknownNCT04738955Phase 4
- Invasive Fungal Infections in Patients Following Stem Cell TransplantCompletedNCT04619147
- ImPACt on Invasive Fungal Infections by Immune Checkpoint InhibitionCompletedNCT04533087
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 3
- Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping StrategyStatus unknownNCT04238884Phase 4
- Anti-fungal Strategies in Acute-on-Chronic Liver Failure PatientsCompletedNCT04157465Not applicable
- Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral AdministrationCompletedNCT04122560Phase 4
- Absorption, Metabolism and Excretion of 14C-olorofim in ManCompletedNCT04039880Phase 1
- Revision of Antifungal Strategies Definitions for Invasive Fungal Infections in Hematological MalignanciesCompletedNCT04024995
- An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDMCompletedNCT04004078
- De-escalation - Antifungal Treatment Immunocompromised PatientsCompletedNCT03774316
- Granulomatous Pneumocystis PneumoniaCompletedNCT03731156
- Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in ChinaCompletedNCT03577509Phase 1
- Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric PatientsCompletedNCT03262584
- A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric PatientsCompletedNCT03241550Phase 1
- Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE StudyCompletedNCT03174457
- Association of Plasma Transfusions and Invasive Fungal InfectionStatus unknownNCT03149562
- Registry of Patients Treated With Systemic Mold-Active TriazolesCompletedNCT03066011
- Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia.CompletedNCT02851680Not applicable
- Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute LeukemiaCompletedNCT02823132
- A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal InfectionsCompletedNCT02678598
- Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU PatientsCompletedNCT02666716
- Cost-Effectiveness of Amphotericin BStatus unknownNCT02527928
- Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care UnitStatus unknownNCT02510053Not applicable
- Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)CompletedNCT02154178Not applicable